CS logo
small CS logo
Merced Heart Associates

Merced, California, United States
Cardiologist in Merced, California
310 Mercy Ave, Merced, CA 95340

About Merced Heart Associates


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Forest Laboratories
2
Abbott
1
AtheroGenics
1
CTI-1, LLC
1
CardioKine Inc.
1
Cogentus Pharmaceuticals
1
Gilead Sciences
1
Otsuka Pharmaceutical Development & Commercialization, Inc.
1
Total Rows: 8

Clinical Trials at Merced Heart Associates


During the past decade, Merced Heart Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation.
2000-12-01
2004-01-01
Completed
431
Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation
2000-09-01
2003-10-01
Completed
446
Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.
2002-09-01
2004-12-01
Completed
600
ARISE - Aggressive Reduction of Inflammation Stops Events
2003-06-01
2006-12-01
Unknown status
6,000
Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure
2004-12-01
2006-12-01
Completed
140
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
2006-03-01
2008-06-01
Completed
318
Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
2007-12-01
2009-11-01
Terminated
5,000
Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure
2010-01-01
Completed
170

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Merced Heart Associates" #1 sponsor was "Forest Laboratories" with 2 trials, followed by "Abbott" with 1 trials sponsored, "AtheroGenics" with 1 trials sponsored, "CTI-1, LLC" with 1 trials sponsored and "CardioKine Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Merced Heart Associates" #1 collaborator was "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "Cardiokine Biopharma, LLC" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsForest Laboratories: 2Forest Laboratories: 2Abbott: 1Abbott: 1AtheroGenics: 1AtheroGenics: 1CTI-1, LLC: 1CTI-1, LLC: 1CardioKine Inc.: 1CardioKine Inc.: 1Cogentus Pharmaceuticals: 1Cogentus Pharmaceuticals: 1Gilead Sciences: 1Gilead Sciences: 1Otsuka PharmaceuticalDevelopment &Commercialization, Inc.:1Otsuka PharmaceuticalDevelopment &Commercialization, Inc.:1

Created with Highcharts 11.1.0Top CollaboratorsCTI Clinical Trial andConsulting Services: 1CTI Clinical Trial andConsulting Services: 1Cardiokine Biopharma, LLC: 1Cardiokine Biopharma, LLC: 1GlaxoSmithKline: 1GlaxoSmithKline: 1Orion Corporation,Orion Pharma: 1Orion Corporation,Orion Pharma: 1

Clinical Trials Conditions at Merced Heart Associates


According to Clinical.Site data, the most researched conditions in "Merced Heart Associates" are "Coronary Artery Disease" (3 trials), "Atrial Fibrillation" (2 trials), "Congestive Heart Failure" (2 trials), "Heart Failure, Congestive" (2 trials) and "Myocardial Infarction" (2 trials). Many other conditions were trialed in "Merced Heart Associates" in a lesser frequency.

Clinical Trials Intervention Types at Merced Heart Associates


Most popular intervention types in "Merced Heart Associates" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Azimilide Dihydrochloride" (2 trials), "AGI-1067" (1 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials) and "Levosimendan" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Merced Heart Associates


The vast majority of trials in "Merced Heart Associates" are 9 trials for "All" genders.

Clinical Trials Status at Merced Heart Associates


Currently, there are NaN active trials in "Merced Heart Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Merced Heart Associates, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Merced Heart Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Phase 2: 2Phase 2: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Terminated: 1Terminated: 1Unknown status: 1Unknown status: 1